Expired Platelet Concentrate Up-Cycling: Growth Factor-Rich Bioproduct Preparation for FBS Substitute

Author:

Lee Eun Hye1,Chun So Young2,Yoon Bo Hyun2,Jeon Minji1,Ha Yun-Sok3ORCID,Chung Jae-Wook3ORCID,Kwon Joonbeom4,Kim Jeongshik5,Hwan Kim Dae6,Park Sang-Joon7ORCID,Kwon Tae Gyun3,Kim Bum Soo3ORCID,Kim Hyun Tae3ORCID

Affiliation:

1. Joint Institute of Regenerative Medicine, Kyungpook National University, Daegu 41566, Republic of Korea

2. BioMedical Research Institute, Kyungpook National University Hospital, Daegu 41940, Republic of Korea

3. Department of Urology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea

4. Department of Urology, Daegu Fatima Hospital, Daegu 41199, Republic of Korea

5. Department of Pathology, Ulsan Joongang Hospital, Ulsan 44667, Republic of Korea

6. Department of Laboratory Animal Research Support Team, Yeungnam University, Daegu 42415, Republic of Korea

7. Department of Histology, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea

Abstract

Due to the short storage period, large quantities of platelet concentrate (PC) are expiring. The expired PC cannot be injected into a blood vessel, but the activity of bioactive molecules, especially growth factors, is still preserved. In this paper, we organized a process to obtain a growth factor-rich bioproduct for use as a supplement in human cell culture by optimizing freezing, thawing, and sterilization conditions. Each unit of PC displayed visual differences, diverse biochemical values, and growth factor concentrations. To minimize lot-to-lot variation, we pooled a minimum of 10 PC units. The concentrations of growth factors were maximized through five freeze–thaw cycles for 12 h at −80 °C for freezing and for 5 min at 36 °C for thawing. We used a cell strainer with 40 µm pores, followed by a 0.45 μm filter and a 0.22 μm filter sequentially to sterilize the bioproduct with minimizing loss. The obtained growth factors remained stable for 4–6 h at room temperature (23 °C), 24 h at 4 °C, and 12 months at −80 °C. Cellular responses to the growth factor-rich bioproduct were tested with primary human renal proximal tubule epithelial cells. The cells exhibited a significantly increased growth rate, compared to the fetal bovine serum (FBS)-treated control group. The cells maintained their characteristic cuboidal shape, and stem cells and renal progenitor cells also preserved their genetic characteristics during culture. Therefore, the growth factor-rich bioproduct isolated from expired PC through our process can be used as a medium supplement to replace FBS in human cell culture for clinical application.

Funder

Kyungpook National University Hospital

Publisher

MDPI AG

Subject

General Medicine

Reference16 articles.

1. Analysis of Discarded Blood Components at a University Hospital in Korea;Kim;Korean J. Blood Transfus.,2011

2. Storage of platelets: Effects associated with high platelet content in platelet storage containers;Gulliksson;Blood Transfus.,2012

3. Recent advances in platelet proteomics;Freson;Expert. Rev. Proteom.,2012

4. Clinical hematology and fundamentals of hemostasis;Harmening;Am. J. Clin. Pathol.,1997

5. Alternatives to the use of fetal bovine serum: Human platelet lysates as a serum substitute in cell culture media;Rauch;ALTEX-Altern. Anim. Exp.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3